Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MIDDLE EAST AND AFRICA PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE OF ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) IN THE AGE OF PATIENT CENTRICITY
5.1.2 GROWING DEMAND FOR ECOA DUE TO ITS CAPABILITY TO COLLECT LARGE AMOUNTS OF DATA WHILE SIMULTANEOUSLY ENSURING HIGH QUALITY
5.1.3 EMERGING TECHNOLOGICAL TRENDS BY PROVIDING A GREATER UNDERSTANDING OF EDC AND ECOA/EPRO PENETRATION IN PHARMACEUTICAL MARKETS
5.1.4 GROWING ACCEPTANCE OF ECOA TO ENGAGE MORE CLOSELY WITH PATIENTS BY PHARMA INDUSTRY
5.1.5 RISING NEED TOWARDS ELECTRONIC DATA CAPTURING FOR EFFICIENCY OF CLINICAL TRIALS
5.1.6 COST-EFFICIENCY AND RELIABILITY PROVIDED BY THE ECOA
5.1.7 RISING NUMBER OF CLINICAL TRIALS REGULATED BY FDA AND APPROVED BY INSTITUTIONAL REVIEW BOARD (IRB) FOR PATIENT SAFETY IN MULTI-CENTER TRIALS
5.2 RESTRAINTS
5.2.1 HIGH INITIAL COSTS ASSOCIATED WITH THE IMPLEMENTATION AND UTILIZATION OF THE SYSTEMS
5.2.2 LACK OF AWARENESS ABOUT REGULATIONS RELATED TO THE DATA MANAGEMENT
5.3 OPPORTUNITIES
5.3.1 RISING LEVELS OF INNOVATIONS AND ADVANCED TECHNOLOGIES
5.3.2 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR CLINICAL RESEARCHES
5.3.3 DIGITIZATION OF CLINICAL TRIALS AIMS AT PERFORMING THEIR END-TO-END DIGITAL TRANSFORMATION
5.3.4 INCREASING COLLABORATION BETWEEN INDUSTRY AND GOVERNMENT FOR CLINICAL TRIALS UNDER GOVERNMENT POLICIES
5.4 CHALLENGES
5.4.1 LACK OF WELL-TRAINED PROFESSIONALS FOR ACCURATE DATA INTERPRETATION
5.4.2 LACK OF PROPER IT INFRASTRUCTURE IN MANY DEVELOPING COUNTRIES
6 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 ON-PREMISE SOLUTIONS
6.3 CLOUD BASED SOLUTIONS
6.4 WEB BASED SOLUTIONS
7 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH
7.1 OVERVIEW
7.2 CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO)
7.3 PATIENT REPORTED OUTCOME ASSESSMENT (PRO)
7.4 OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO)
7.5 PERFORMANCE OUTCOME ASSESSMENT (PERFO)
8 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER
8.1 OVERVIEW
8.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS
8.3 HOSPITALS AND TRANSPLANT CENTERS
8.4 COMMERCIAL SERVICE PROVIDERS
9 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM
9.1 OVERVIEW
9.2 CONTRACT RESEARCH ORGANIZATIONS
9.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
9.4 MEDICAL DEVICE MANUFACTURERS
9.5 HOSPITALS AND CLINICAL LABORATORIES
9.6 CONSULTING SERVICE COMPANIES
9.7 RESEARCH AND ACADEMIA
9.8 OTHERS
10 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT FOR CONTENT LICENSED MARKET, BY REGION
10.1 MIDDLE EAST AND AFRICA
10.1.1 SOUTH AFRICA
10.1.2 UAE
10.1.3 ISRAEL
10.1.4 SAUDI ARABIA
10.1.5 EGYPT
10.1.6 REST OF MIDDLE EAST AND AFRICA
11 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT FOR CONTENT LICENSED MARKET: COMPANY LANDSCAP
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
12 SWOT ANALYSIS
13 COMPANY PROFILE
13.1 ORACLE
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 PAREXEL INTERNATIONAL CORPORATION
13.2.1 COMPANY SNAPSHOT
13.2.2 COMPANY SHARE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENTS
13.3 ERT CLINICAL
13.3.1 COMPANY SNAPSHOT
13.3.2 COMPANY SHARE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 DASSAULT SYSTÈMES
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 BIOCLINICA
13.5.1 COMPANY SNAPSHOT
13.5.2 COMPANY SHARE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 IBM CORPORATION
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 CLINICAL INK
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 KAYENTIS
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 ANJU SOFTWARE, INC.
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 ARISMIDDLE EAST AND AFRICA
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENTS
13.11 ECLINICAL SOLUTIONS LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENTS
13.12 SIGNANT HEALTH
13.12.1 COMPANY SNAPSHOT
13.12.2 SOLUTION PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 WIRB-COPERNICUS GROUP
13.13.1 COMPANY SNAPSHOT
13.13.2 SERVICE PORTFOLIO
13.13.3 RECENT DEVELOPMENTS
13.14 YPRIME LLC
13.14.1 COMPANY SNAPSHOT
13.14.2 PRODUCT PORTFOLIO
13.14.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 2 MIDDLE EAST AND AFRICA ON-PREMISE SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 3 MIDDLE EAST AND AFRICA CLOUD BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA WEB BASED SOLUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 6 MIDDLE EAST AND AFRICA CLINICIAN REPORTED OUTCOME ASSESSMENT (CLINRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA PATIENT REPORTED OUTCOME ASSESSMENT (PRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA OBSERVER REPORTED OUTCOME ASSESSMENT (OBSRO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 9 MIDDLE EAST AND AFRICA PERFORMANCE OUTCOME ASSESSMENT (PERFO) IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA HOSPITALS AND TRANSPLANT CENTERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA COMMERCIAL SERVICE PROVIDERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA MEDICAL DEVICE MANUFACTURERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA HOSPITALS AND CLINICAL LABORATORIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA CONSULTING SERVICE COMPANIES IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA RESEARCH AND ACADEMIA IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA OTHERS IN ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY COUNTRY, 2019-2028 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 27 SOUTH AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 28 SOUTH AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 29 SOUTH AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 30 SOUTH AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 31 UAE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 32 UAE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 33 UAE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 34 UAE ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 35 ISRAEL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 36 ISRAEL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 37 ISRAEL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 38 ISRAEL ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 39 SAUDI ARABIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 40 SAUDI ARABIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 41 SAUDI ARABIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 42 SAUDI ARABIA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 43 EGYPT ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 44 EGYPT ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY APPROACH, 2019-2028 (USD THOUSAND)
TABLE 45 EGYPT ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY END USER, 2019-2028 (USD THOUSAND)
TABLE 46 EGYPT ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PLATFORM, 2019-2028 (USD THOUSAND)
TABLE 47 REST OF MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: SEGMENTATION
FIGURE 10 GROWING ACCEPTANCE OF ECOA TO ENGAGE MORE CLOSELY WITH PATIENTS BY PHARMA INDUSTRY IS EXPECTED TO DRIVE MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 11 ON-PREMISE SOLUTIONS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET IN 2021 & 2028
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET
FIGURE 13 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY PRODUCT, 2020
FIGURE 14 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY APPROACH, 2020
FIGURE 15 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY END USER, 2020
FIGURE 16 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY PLATFORM, 2020
FIGURE 17 MIDDLE EAST AND AFRICA ELECTRONIC OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: SNAPSHOT (2020)
FIGURE 18 MIDDLE EAST AND AFRICA ELECTRONIC OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY GEOGRAPHY (2020)
FIGURE 19 MIDDLE EAST AND AFRICA ELECTRONIC OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY GEOGRAPHY (2021 & 2028)
FIGURE 20 MIDDLE EAST AND AFRICA ELECTRONIC OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY GEOGRAPHY (2020 & 2028)
FIGURE 21 MIDDLE EAST AND AFRICA ELECTRONIC OUTCOME ASSESSMENT (ECOA) FOR CONTENT LICENSED MARKET: BY PRODUCT (2021-2028)
FIGURE 22 MIDDLE EAST AND AFRICA ELECTRONIC CLINICAL OUTCOME ASSESSMENT FOR CONTENT LICENSED MARKET: COMPANY SHARE 2020(%)
